TY - JOUR AU - Rayan, G. M. PY - 2007 DA - 2007// TI - Dupuytren disease: anatomy, pathology, presentation, and treatment JO - J Bone Joint Surg Am VL - 89 UR - https://doi.org/10.2106/00004623-200701000-00026 DO - 10.2106/00004623-200701000-00026 ID - Rayan2007 ER - TY - JOUR AU - Shih, B. AU - Bayat, A. PY - 2010 DA - 2010// TI - Scientific understanding and clinical management of Dupuytren disease JO - Nat Rev Rheumatol VL - 6 UR - https://doi.org/10.1038/nrrheum.2010.180 DO - 10.1038/nrrheum.2010.180 ID - Shih2010 ER - TY - JOUR AU - Michou, L. AU - Lermusiaux, J. L. AU - Teyssedou, J. P. AU - Bardin, T. AU - Beaudreuil, J. PY - 2012 DA - 2012// TI - Genetics of Dupuytren’s disease JO - Joint Bone Spine VL - 79 UR - https://doi.org/10.1016/j.jbspin.2011.05.027 DO - 10.1016/j.jbspin.2011.05.027 ID - Michou2012 ER - TY - JOUR AU - Arkkila, P. E. AU - Kantola, I. M. AU - Viikari, J. S. PY - 1997 DA - 1997// TI - Dupuytren’s disease: association with chronic diabetic complications JO - J Rheumatol VL - 24 ID - Arkkila1997 ER - TY - JOUR AU - Mikkelsen, O. A. PY - 1977 DA - 1977// TI - Dupuytren’s disease-initial symptoms, age of onset and spontaneous course JO - Hand VL - 9 UR - https://doi.org/10.1016/S0072-968X(77)80023-5 DO - 10.1016/S0072-968X(77)80023-5 ID - Mikkelsen1977 ER - TY - JOUR AU - Tomasek, J. J. AU - Vaughan, M. B. AU - Haaksma, C. J. PY - 1999 DA - 1999// TI - Cellular structure and biology of Dupuytren’s disease JO - Hand Clin VL - 15 ID - Tomasek1999 ER - TY - JOUR AU - Tomasek, J. J. AU - Gabbiani, G. AU - Hinz, B. PY - 2002 DA - 2002// TI - Myofibroblasts and mechano-regulation of connective tissue remodeling JO - Nat Rev Mol Cell Biol VL - 3 UR - https://doi.org/10.1038/nrm809 DO - 10.1038/nrm809 ID - Tomasek2002 ER - TY - JOUR AU - Shaw, R. B. AU - Chong, A. K. AU - Zhang, A. PY - 2007 DA - 2007// TI - Dupuytren’s disease: history, diagnosis, and treatment JO - Plast Reconstr Surg VL - 120 UR - https://doi.org/10.1097/01.prs.0000278455.63546.03 DO - 10.1097/01.prs.0000278455.63546.03 ID - Shaw2007 ER - TY - JOUR AU - Lanting, R. AU - Broekstra, D. C. AU - Werker, P. M. AU - Heuvel, E. R. PY - 2014 DA - 2014// TI - A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries JO - Plast Reconstr Surg VL - 133 UR - https://doi.org/10.1097/01.prs.0000438455.37604.0f DO - 10.1097/01.prs.0000438455.37604.0f ID - Lanting2014 ER - TY - JOUR AU - Dibenedetti, D. B. AU - Nguyen, D. AU - Zografos, L. AU - Ziemiecki, R. AU - Zhou, X. PY - 2011 DA - 2011// TI - Prevalence, incidence, and treatments of Dupuytren’s disease in the United States: Results from a population-based study JO - Hand (NY) VL - 6 UR - https://doi.org/10.1007/s11552-010-9306-4 DO - 10.1007/s11552-010-9306-4 ID - Dibenedetti2011 ER - TY - JOUR AU - Macaulay, D. AU - Ivanova, J. AU - Birnbaum, H. AU - Sorg, R. AU - Skodny, P. PY - 2012 DA - 2012// TI - Direct and indirect costs associated with Dupuytren’s contracture JO - J Med Econ VL - 15 UR - https://doi.org/10.3111/13696998.2012.670678 DO - 10.3111/13696998.2012.670678 ID - Macaulay2012 ER - TY - JOUR AU - Rijssen, A. L. AU - Linden, H. AU - Werker, P. M. PY - 2012 DA - 2012// TI - Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy JO - Plast Reconstr Surg VL - 129 UR - https://doi.org/10.1097/PRS.0b013e31823aea95 DO - 10.1097/PRS.0b013e31823aea95 ID - Rijssen2012 ER - TY - JOUR AU - Hurst, L. C. AU - Badalamente, M. A. AU - Hentz, V. R. AU - Hotchkiss, R. N. AU - Kaplan, F. T. AU - Meals, R. A. AU - Smith, T. M. AU - Rodzvilla, J. PY - 2009 DA - 2009// TI - CORD I Study Group. Injectable collagenase clostridium for Dupuytren’s contracture JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0810866 DO - 10.1056/NEJMoa0810866 ID - Hurst2009 ER - TY - JOUR AU - Rozen, W. M. AU - Edirisinghe, Y. AU - Crock, J. PY - 2012 DA - 2012// TI - Late complications of clinical clostridium histolyticum collagenase use in Dupuytren’s disease JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0043406 DO - 10.1371/journal.pone.0043406 ID - Rozen2012 ER - TY - STD TI - Povlsen B, Singh S. Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren’s contracture. BMJ Case Rep. 2014. ID - ref15 ER - TY - JOUR AU - Worrell, M. PY - 2012 DA - 2012// TI - Dupuytren’s disease JO - Orthopedics VL - 35 UR - https://doi.org/10.3928/01477447-20111122-23 DO - 10.3928/01477447-20111122-23 ID - Worrell2012 ER - TY - JOUR AU - Badalamente, M. A. AU - Sampson, S. P. AU - Hurst, L. C. AU - Dowd, A. AU - Miyasaka, K. PY - 1996 DA - 1996// TI - The role of transforming growth factor beta in Dupuytren’s disease JO - J Hand Surg [Am] VL - 21 UR - https://doi.org/10.1016/S0363-5023(96)80102-X DO - 10.1016/S0363-5023(96)80102-X ID - Badalamente1996 ER - TY - JOUR AU - Vaughan, M. B. AU - Howard, E. W. AU - Tomasek, J. J. PY - 2000 DA - 2000// TI - Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast JO - Exp Cell Res VL - 257 UR - https://doi.org/10.1006/excr.2000.4869 DO - 10.1006/excr.2000.4869 ID - Vaughan2000 ER - TY - JOUR AU - Satish, L. AU - Gallo, P. H. AU - Baratz, M. E. AU - Johnson, S. AU - Kathju, S. PY - 2011 DA - 2011// TI - Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren’s-derived fibroblasts JO - BMC Musculoskelet Disord VL - 12 UR - https://doi.org/10.1186/1471-2474-12-113 DO - 10.1186/1471-2474-12-113 ID - Satish2011 ER - TY - JOUR AU - Swaney, J. S. AU - Roth, D. M. AU - Olson, E. R. AU - Naugle, J. E. AU - Meszaros, G. J. AU - Insel, P. A. PY - 2005 DA - 2005// TI - Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase JO - Proc Natl Acad Sci VL - 102 UR - https://doi.org/10.1073/pnas.0408704102 DO - 10.1073/pnas.0408704102 ID - Swaney2005 ER - TY - JOUR AU - Liu, X. AU - Ostrom, R. S. AU - Insel, P. A. PY - 2004 DA - 2004// TI - cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts JO - Am J Physiol VL - 286 UR - https://doi.org/10.1152/ajpcell.00461.2003 DO - 10.1152/ajpcell.00461.2003 ID - Liu2004 ER - TY - JOUR AU - Kavitha, C. AU - Rajamani, K. AU - Vadivel, E. PY - 2010 DA - 2010// TI - Coleus forskohlii- A comprehensive review on morphology, phytochemistry and pharmacological aspects JO - J Med Plants Res VL - 4 ID - Kavitha2010 ER - TY - JOUR AU - Noble, P. W. AU - Albera, C. AU - Bradford, W. Z. PY - 2011 DA - 2011// TI - Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60405-4 DO - 10.1016/S0140-6736(11)60405-4 ID - Noble2011 ER - TY - JOUR AU - Al-Bayati, M. A. AU - Xie, Y. AU - Mohr, F. C. PY - 2002 DA - 2002// TI - Effect of pirfenidone against vanadate-induced kidney fibrosis in rats JO - Biochem Pharmacol VL - 64 UR - https://doi.org/10.1016/S0006-2952(02)01213-3 DO - 10.1016/S0006-2952(02)01213-3 ID - Al-Bayati2002 ER - TY - JOUR AU - Lee, K. W. AU - Everett, T. H. AU - Rahmutula, D. PY - 2006 DA - 2006// TI - Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.624320 DO - 10.1161/CIRCULATIONAHA.106.624320 ID - Lee2006 ER - TY - JOUR AU - Sario, A. AU - Bendia, E. AU - Macarri, G. PY - 2004 DA - 2004// TI - The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1 (I), TIMP-1 and MMP-2 JO - Dig Liver Dis VL - 36 UR - https://doi.org/10.1016/j.dld.2004.05.012 DO - 10.1016/j.dld.2004.05.012 ID - Sario2004 ER - TY - JOUR AU - Armendariz-Borunda, J. AU - Lyra-Gonzalez, I. AU - Medina-Preciado, D. PY - 2012 DA - 2012// TI - A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients JO - Ann Plast Surg VL - 68 UR - https://doi.org/10.1097/SAP.0b013e31821b6d08 DO - 10.1097/SAP.0b013e31821b6d08 ID - Armendariz-Borunda2012 ER - TY - JOUR AU - Lasky, J. PY - 2004 DA - 2004// TI - Pirfenidone JO - IDrugs VL - 7 ID - Lasky2004 ER - TY - JOUR AU - Hewitson, T. D. AU - Kelynack, K. J. AU - Tait, M. G. PY - 2001 DA - 2001// TI - Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis JO - J Nephrol VL - 14 ID - Hewitson2001 ER - TY - JOUR AU - Thannickal, Y. J. AU - Flaherty, K. R. AU - Martinez, F. J. AU - Lynch, J. P. PY - 2004 DA - 2004// TI - iii: Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy JO - Expert Opin Pharmacother VL - 5 UR - https://doi.org/10.1517/14656566.5.8.1671 DO - 10.1517/14656566.5.8.1671 ID - Thannickal2004 ER - TY - JOUR AU - Satish, L. AU - Palmer, B. AU - Liu, F. AU - Papatheodorou, L. AU - Rigatti, L. AU - Baratz, M. E. AU - Kathju, S. PY - 2015 DA - 2015// TI - Developling an animal model of Dupuytren’s diseaseby orthotopic transplantation of human fibroblasts into athymic rat JO - BMC Musculoskelt Disord VL - 16 UR - https://doi.org/10.1186/s12891-015-0597-z DO - 10.1186/s12891-015-0597-z ID - Satish2015 ER - TY - JOUR AU - Satish, L. AU - O’Gorman, D. B. AU - Johnson, S. AU - Raykha, C. AU - Gan, B. S. AU - Wang, J. H. AU - Kathju, S. PY - 2013 DA - 2013// TI - Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren’s contracture JO - Cell Stress Chaperones VL - 18 UR - https://doi.org/10.1007/s12192-012-0392-9 DO - 10.1007/s12192-012-0392-9 ID - Satish2013 ER - TY - JOUR AU - Brickley-Parsons, D. AU - Glimcher, M. J. AU - Smith, R. J. AU - Albin, R. AU - Adams, J. P. PY - 1981 DA - 1981// TI - Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren’s disease JO - J Bone Joint Surg Am VL - 63 UR - https://doi.org/10.2106/00004623-198163050-00014 DO - 10.2106/00004623-198163050-00014 ID - Brickley-Parsons1981 ER - TY - JOUR AU - Howard, J. C. AU - Varallo, V. M. AU - Ross, D. C. AU - Faber, K. J. AU - Roth, J. H. AU - Seney, S. AU - Gan, B. S. PY - 2004 DA - 2004// TI - Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren’s contracture JO - J Surg Res VL - 117 UR - https://doi.org/10.1016/j.jss.2004.01.013 DO - 10.1016/j.jss.2004.01.013 ID - Howard2004 ER - TY - JOUR AU - Vi, L. AU - Feng, L. AU - Zhu, R. D. AU - Wu, Y. AU - Satish, L. AU - Gan, B. S. AU - O’Gorman, D. B. PY - 2009 DA - 2009// TI - Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren’s disease and adjacent palmar fascia cells JO - Exp Cell Res VL - 315 UR - https://doi.org/10.1016/j.yexcr.2009.07.015 DO - 10.1016/j.yexcr.2009.07.015 ID - Vi2009 ER - TY - JOUR AU - Krause, C. AU - Kloen, P. AU - Dijke, P. T. PY - 2011 DA - 2011// TI - Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren’s disease fibroblasts JO - Fibrogenesis Tissue Repair VL - 4 UR - https://doi.org/10.1186/1755-1536-4-14 DO - 10.1186/1755-1536-4-14 ID - Krause2011 ER - TY - JOUR AU - Satish, L. AU - LaFramboise, W. A. AU - Johnson, S. AU - Vi, L. AU - Njarlangattil, A. AU - Raykha, C. AU - Krill-Burger, J. M. AU - Gallo, P. H. AU - O’Gorman, D. B. AU - Gan, B. S. AU - Baratz, M. E. AU - Ehrlich, G. D. AU - Kathju, S. PY - 2012 DA - 2012// TI - Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren’s Contracture JO - BMC Med Genomics VL - 5 UR - https://doi.org/10.1186/1755-8794-5-15 DO - 10.1186/1755-8794-5-15 ID - Satish2012 ER - TY - JOUR AU - Meyer, A. AU - Wang, W. AU - Qu, J. AU - Croft, L. AU - Degen, J. L. AU - Coller, B. S. AU - Ahamed, J. PY - 2012 DA - 2012// TI - Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-09-377648 DO - 10.1182/blood-2011-09-377648 ID - Meyer2012 ER - TY - JOUR AU - Cutolo, C. A. AU - Lombardo, S. AU - Verticchio Vercellin, A. C. AU - Bertonr, C. AU - Amici, M. AU - Antoniazzi, E. AU - Milano, G. PY - 2013 DA - 2013// TI - Cataracts and Dupuytren disease: a case report and review of the literature JO - Eur J Opthalmol VL - 23 ID - Cutolo2013 ER - TY - JOUR AU - Shi, Q. AU - Liu, X. AU - Bai, Y. AU - Cui, C. AU - Li, J. AU - Li, Y. AU - Hu, S. AU - Wei, Y. PY - 2011 DA - 2011// TI - In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0028134 DO - 10.1371/journal.pone.0028134 ID - Shi2011 ER - TY - JOUR AU - Lin, X. AU - Yu, M. AU - Wu, K. AU - Yuan, H. AU - Zhong, H. PY - 2009 DA - 2009// TI - Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon’s fibroblasts in vitro Invest JO - Ophthalmol Vis Sci VL - 50 UR - https://doi.org/10.1167/iovs.08-2815 DO - 10.1167/iovs.08-2815 ID - Lin2009 ER - TY - JOUR AU - Xiang, X. H. AU - Jiang, T. P. AU - Zhang, S. AU - Song, J. AU - Li, X. AU - Yang, J. Y. AU - Zhou, S. PY - 2015 DA - 2015// TI - Pirfenidone inhibits proliferation, arrests the cell cycle, and downregulates heat shock protein-47 and collagen type I in rat hepatic stellate cells in vitro JO - Mol Med Rep VL - 12 ID - Xiang2015 ER - TY - JOUR AU - Knobloch, K. AU - Redeker, J. AU - Vogt, P. M. PY - 2009 DA - 2009// TI - Antifibrotic medication using a combination of N-acetyl-L-cystein (NAC) and ACE inhibitors can prevent the recurrence of Dupuytren’s disease JO - Med Hypotheses VL - 73 UR - https://doi.org/10.1016/j.mehy.2009.08.011 DO - 10.1016/j.mehy.2009.08.011 ID - Knobloch2009 ER - TY - JOUR AU - Derynck, R. AU - Zhang, Y. E. PY - 2003 DA - 2003// TI - Smad-dependent and Smad-independent pathways in TGF-beta family signalling JO - Nature VL - 425 UR - https://doi.org/10.1038/nature02006 DO - 10.1038/nature02006 ID - Derynck2003 ER - TY - JOUR AU - Xu, J. AU - Lamouille, S. AU - Derynck, R. PY - 2009 DA - 2009// TI - TGF-beta-induced epithelial to mesenchymal transition JO - Cell Res VL - 19 UR - https://doi.org/10.1038/cr.2009.5 DO - 10.1038/cr.2009.5 ID - Xu2009 ER - TY - JOUR AU - Yuan, Q. AU - Wang, L. AU - Zhang, F. AU - Wang, R. AU - Fu, X. AU - Peng, Z. AU - Ning, W. AU - Hu, G. AU - Wang, Z. AU - Tao, L. PY - 2011 DA - 2011// TI - Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells JO - Pharmazie VL - 66 ID - Yuan2011 ER - TY - JOUR AU - Yang, Y. AU - Ye, Y. AU - Lin, X. AU - Wu, K. AU - Yu, M. PY - 2013 DA - 2013// TI - Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithelial-mesenchymal transition of human lens epithelial cells line SRA01/04 JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0056837 DO - 10.1371/journal.pone.0056837 ID - Yang2013 ER - TY - JOUR AU - Choi, K. AU - Lee, K. AU - Ryu, S. W. AU - Im, M. AU - Kook, K. H. AU - Choi, C. PY - 2012 DA - 2012// TI - Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19 JO - Mol Vis VL - 18 ID - Choi2012 ER - TY - JOUR AU - Wang, J. AU - Yang, Y. AU - Xu, J. AU - Lin, X. AU - Wu, K. AU - Yu, M. PY - 2013 DA - 2013// TI - Pirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro JO - Mol Vis VL - 19 ID - Wang2013 ER - TY - JOUR AU - Rodríguez-Castellanos, M. AU - Tlacuilo-Parra, A. AU - Sánchez-Enríquez, S. AU - Vélez-Gómez, E. AU - Guevera-Gutiérrez, E. PY - 2015 DA - 2015// TI - Pirfenidone gel in patients with localized scleroderma: a phase II study JO - Arthritis Res Ther VL - 16 UR - https://doi.org/10.1186/s13075-014-0510-4 DO - 10.1186/s13075-014-0510-4 ID - Rodríguez-Castellanos2015 ER -